using rifampin WITH pyrazinamide for latent tuberculosis
October 2001
There are new warnings about using rifampin WITH pyrazinamide for latent tuberculosis.
Since the CDC recommended the combo last year, there have been 23 cases of liver injury...twice the amount seen with other regimens.
Now the CDC recommends patient evaluations every two weeks when using rifampin with pyrazinamide for latent TB...and to avoid the combo in patients with liver disease or previous isoniazid hepatotoxicity.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote